MedinCell S.A. Profile Avatar - Palmy Investing

MedinCell S.A.

MedinCell S.A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceuti…

Biotechnology
FR, Jacou [HQ]
Lobbying · US Senate · Influence

Lobbying Analysis

MedinCell S.A. has no lobbying expenses in our database.
FY Quarter Lobby Expense [in mil. $] Filing Report Time
No data
End of MEDCL.PA's Analysis
CIK: - CUSIP: F6104D107 ISIN: FR0004065605 LEI: - UEI: -
Secondary Listings
MEDCL.PA has no secondary listings inside our databases.